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Since 2005, two cases of natural bovine spongiform encephalopathies (BSE) have been reported in 
goats. Furthermore, experimental transmissions of classical (C-BSE) and atypical (L-BSE) forms of BSE 
in goats were also reported. To minimize further spreading of prion diseases in small ruminants the 
development of a highly sensitive and specific test for ante-mortem detection of infected animals would 
be of great value. Recent studies reported high diagnostic value of a second generation of cerebrospinal 
fluid (CSF) Real-Time Quaking-Induced Conversion (RT-QuIC) assay across a wide spectrum of human 
prions. Here, we applied this improved QuIC (IQ-CSF) for highly efficient detection of TSEs prion 
protein in goat cerebrospinal fluid. IQ-CSF sensitivity and specificity were evaluated on CSF samples 
collected at disease endpoint from goats naturally and experimentally infected with scrapie or bovine 
isolates of C-BSE and L-BSE, respectively. Next, CSF samples collected from L-BSE infected goats 
during pre-symptomatic stage were also analysed. PrPL-BSE associated seeding activity was detected 
at early time points after experimental inoculation, with an average time of 439 days before clinical 
symptoms appeared. Taken together these data are indicative of the great potential of this in vitro prion 
amplification assay as ante-mortem TSE test for live and asymptomatic small ruminants.
Transmissible Spongiform Encephalopathies (TSEs) or prion diseases are fatal neurodegenerative diseases that 
include Creutzfeldt-Jakob disease (CJD) in humans, bovine spongiform encephalopathy (BSE) in cattle, scrapie 
in sheep and chronic wasting disease (CWD) in cervids. The infectious agent responsible for these diseases, the 
prion, appears to be composed primarily of an abnormal, misfolded and oligomeric (PrPSc) form of the cellular 
prion protein (PrPC)1,2. PrPSc induces the polymerization and conformational conversion of PrPC to its infectious 
form3–5 or, in a variety of in vitro conversion assays6, into alternative forms of the prion protein which are, simi-
larly to PrPSc, partially resistant to digestion with proteases (PrPRes). The pathogenic isoform of the prion protein 
is therefore a marker associated to TSEs which acts as a seed allowing the ultrasensitive detection of PrPSc using 
in vitro prion amplification reactions such as Real-Time Quaking Induced Conversion (RT-QuIC)7.
The spread of BSE agent to small ruminants is a major issue in the surveillance of TSEs because BSE passage 
into a new host may change strain properties, make it difficult to recognize the original strain, and increasing 
the risk of epidemic spread8. Since 2005, two natural BSE cases have been reported in goats9,10. Furthermore, 
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experimental transmissions of classical (C-BSE) and atypical (L-BSE) forms of BSE in goats were also reported11. 
An important goal to minimize further spreading of small ruminant TSEs is the development of an assay for 
highly sensitive and intra-vitam detection of prions in infected, but not clinically sick animals. Currently, small 
ruminant TSEs are definitively diagnosed by post-mortem examinations of brain stem to detect PrPSc 12. RT-QuIC 
assays can rapidly detect sub-infectious levels of prion seeding activity and have been used successfully to detect 
multiple human, cervid, ovine, hamster, and mouse prion strains in a variety of biological tissues, such as skin13, 
cerebrospinal fluid14–18, saliva19, blood20–23, and nasal brushings24, showing that this test has the potential of being 
used for ante-mortem TSE diagnosis. Important studies on human cerebrospinal fluid from patients with sporadic 
Creutzfeldt-Jakob disease (sCJD) have shown that RT-QuIC has the potential to improve ante-mortem diagnosis 
for this disease, with a high degree of specificity15–17,25–29. Results obtained by several laboratories with the first 
generation of this assay (referred to here as previous QuIC-CSF [PQ-CSF]), mainly using full-length (23–231) 
hamster recombinant PrP (rPrPSen) as the substrate, demonstrated a very high specificity but a suboptimal sensi-
tivity, especially in sCJD subtypes associated with PrPSc type 230,31. However, Orrù et al.25 recently introduced an 
improved, second generation RT-QuIC for CSF (referred to here as improved QuIC-CSF [IQ-CSF]) assay which 
uses a truncated form of hamster rPrPSen (amino acids 90–231) as the substrate, higher incubation temperatures, 
and the addition of SDS. Initial evaluation of the IQ-CSF assay indicated greater analytical and diagnostic sensi-
tivity, and markedly shorter testing times25–29.
Studies have demonstrated that CSF tests that measure alterations in total PrP levels and prion seeding activ-
ity by RT-QuIC, may be useful in the identification of pre-clinical prion cases20,32. Still, it remains important to 
understand the time course of prion seeding activity accumulation in cerebrospinal fluid of prion-infected small 
ruminants in order to develop an early, sensitive, and specific test for ante-mortem and pre-clinical detection 
of PrPSc. Furthermore, to date there is no information on experimental conditions to amplify goat BSE prion 
strains by RT-QuIC. Moreover, IQ-CSF conditions have not been previously applied to animal CSF samples. 
Here, we report for the first time sensitive detection of different small ruminant prion strains in brain and CSF of 
TSE-infected goats by RT-QuIC assays. Furthermore, intra-vitam detection of preclinical L-BSE-infected goats 
at early time points is also described. Taken together these data are indicative of the great potential of this in vitro 
prion amplification assay as ante-mortem TSE test for live and asymptomatic small ruminants.
Results
RT-QuIC seeding activity in brains from natural scrapie and experimental C-BSE- and L-BSE-
infected goats. To test the presence of PrPSc before proceeding to subsequent RT-QuIC analyses, Western 
Blot (WB) analyses were carried out on brainstem collected from experimental C-BSE and L-BSE infected goats 
(Table 1), recently characterized in our work by Vallino Costassa et al.11. Brain tissue from cattle C-BSE and L-BSE 
samples, used for the inoculum, and previously confirmed classical scrapie goats served as controls. Western 
Blot analyses revealed strong immunosignals related to the presence of pathological prion protein in all analysed 
samples (Fig. 1).
Chimeric hamster-sheep (Ha-S) rPrPSen was first used as substrate to evaluate RT-QuIC for the detection 
of different goat prion strains seeding activity in brain samples. A rapid increase in ThT fluorescence, indic-
ative of newly formed seeded rPrP amyloid fibrils, was observed in each quadruplicate reaction seeded with 
10−4 TSE-infected brain tissue dilutions within 24 h (Fig. 2A). As previously observed for brain homogenate 
samples from cattle33, the average fluorescence increase was stronger and faster for the L-BSE-infected sam-
ples, showing positive signals over the control samples as early as 5 h, compared to the 10–15 h it took for the 
BSE and scrapie-infected samples. Although the three goat prion strains exhibited distinct RT-QuIC seeded 




PrPSc PrPSc peripheral distribution
G1 C-BSE Saanen 2 IC ARQ/ARQ; 240 P/P + subm.ln, retroph.ln, spleen
G2 C-BSE Saanen 2 IC ARQ/ARQ; 240 P/P + subm.ln, retroph.ln, par. ln, icv, spleen
G3 L-BSE Saanen 3 IC ARQ/ARQ; 240 P/P + −
G4 L-BSE Saanen 3 IC ARQ/ARQ; 240 P/P + −
G5 L-BSE Saanen 3 IC ARQ/ARQ; 240 P/P + −
G6 L-BSE Saanen 3 IC ARQ/ARQ; 240 P/P + −
G7 L-BSE Saanen 3 IC ARQ/ARQ; 240 S/P + −
G8 L-BSE Saanen 3 IC ARQ/ARQ; 240 P/P + −
G9 C-BSE Saanen 2 IC ARQ/ARQ; 240 S/P + subm.ln, retroph.ln, par. ln, icv, spleen
G10 C-BSE Saanen 2 IC ARQ/ARQ; 240 P/P + subm.ln, retroph.ln,tonsils
G11 C-BSE Saanen 2 IC ARQ/ARQ; 240 P/P + n. a.
Sc 1 scrapie Mixed Breed 5 Natural 222 Q/Q + n. a.
Sc 2 scrapie Mixed Breed 2 Natural 222 Q/Q + n. a.
CTR 1 None Mixed Breed 5 − ARQ/ARQ; 240 P/P − −
CTR 2 None Saanen 2 − ARQ/ARQ; 240 P/P − −
Table 1. Study Populations. Breed, age, route of prion infection, genotype, CNS PrPSc and PrPSc peripheral 
distribution. IC = intracranial; n. a. = not available.
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polymerization kinetics, our results show that Ha-S rPrPSen supports detection of goat C-BSE-, L-BSE- and 
scrapie-associated seeding activity.
Next, RT-QuIC end-point dilution analysis of three representative clinical TSE-infected goat brain homoge-
nates was performed to evaluate the detection sensitivity for each goat prion strain previously tested. We saw 
positive reactions with all prion strains using infected brain tissue dilutions down to 10−8 (Fig. 2B,D), although 
reactions seeded with more diluted scrapie samples (10−8) were positive only by 40 h incubation (Fig. 2D). This 
sensitivity was similar to that reported previously for rodent and human prion samples14. Spontaneous (unseeded) 
amyloid formation (rPrPspon) was observed in only one of the quadruplicate reactions seeded with normal brain 
tissue dilutions at 70 h (data not shown). Therefore, we chose 60 h as the reaction cut-off.
In order to explore the prion strain properties of goat C-BSE and L-BSE we tested their relative abilities to 
initiate polymerization of hamster 90–231 rPrPSen substrate. RT-QuIC reactions were seeded with 10−4 to 10−8 
brain tissue dilutions and incubated for 60 h using the same experimental conditions described for Ha-S rPrPSen. 
Both goat BSE prion strains induced conformational conversion of Ha rPrPSen 90–231 giving the fastest response 
reactions with the L-BSE seed (Fig. 2E). Conversely to cattle C-BSE33, goat C-BSE was able to seed conversion of 
hamster 90–231 rPrPSen substrate under these conditions although the sensitivity was limited to less diluted brain 
tissue homogenates (Fig. 2F).
High diagnostic value of IQ-CSF across the broad spectrum of small ruminant prions. PQ-CSF 
and IQ-CSF performances were compared in order to develop experimental conditions for ante-mortem detec-
tion of prion-infected small ruminants. As previously reported for RT-QuIC-based sCJD diagnosis using CSF 
samples and N-terminally truncated hamster rPrPSen (90–231), we found initially that when pure goat CSF was 
analyzed, positive reactions occurred only after 40 h. However, pure CSF specimens lack SDS that was present in 
the previously studied brain homogenates, so we then applied RT-QuIC using the combination of the rHaPrPSen 
90–231 substrate, 55 °C, and 0.002% SDS (referred to here as improved QuIC-CSF [IQ-CSF] conditions) to an 
initial panel of CSF samples collected from two symptomatic L-type BSE-infected goats and two patients affected 
with sCJD (compare Fig. 3A,B). Our findings indicated that we can sensitively detect PrPSc associated seeding 
activity using IQ-CSF in less than 10 h.
Next, we also tested the effects of IQ-CSF conditions on CSF-seeded reaction mixtures using each goat prion 
strain and Ha 90–231 rPrPSen as substrate. Notably, 3 of the 3 samples that did not give positive responses under 
the PQ-CSF conditions (Fig. 3C), gave strong responses using the IQ-CSF conditions (Fig. 3D), while samples 
from non-TSE control cases remained negative. These findings provided initial evidence that these new reaction 
conditions improve the speed and diagnostic sensitivity of the RT-QuIC CSF assay for prion goat diseases while 
maintaining full specificity.
Figure 1. Western blot analysis of brainstem of goats inoculated with C- or L-Type BSE. (A) PrPSc was extracted 
from the brainstem of two representative goats inoculated with C-type BSE (G1, G2). Brain tissue from cattle 
C-BSE, used for the inoculum, and previously confirmed classical scrapie goat (Sc 1) served as positive controls. 
(B) PrPSc was extracted from the brainstem of two representative goats inoculated with L-type BSE (G3, G4). 
Brain tissue from cattle L-BSE, used for the inoculum, and previously confirmed classical scrapie goats (Sc 2) 
served as controls. All samples were treated with Proteinase K. Applied tissue equivalents were 3 mg (C-BSE 
goats) or 8 mg (L-Type BSE goats). Membranes were probed with mAb SAF 84. Full length blots including 
negative controls and all goats inoculated with C- or L-type BSE are presented in Supplementary Figs S1 and S2, 
respectively.
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Early Detection of PrPSc in CSF of asymptomatic L-BSE infected goats by IQ-CSF. To investi-
gate the potential of RT-QuIC to detect seeding activity at early time points after inoculation we applied IQ-CSF 
RT-QuIC to goat CSF collected from 3 L-BSE-infected goats during the pre-symptomatic stage (Table 2). Highly 
efficient detection of PrPL-BSE associated seeding activity was revealed with an average time of 439 days before 
clinical symptoms appeared (Fig. 4A).
Next, we compared the analytical sensitivities of RT-QuIC using IQ-CSF conditions on CSF samples collected 
at clinical onset and during pre-symptomatic stage that gave positive reactions in the above-described analyses. 
Four replicate reactions seeded with serial decreasing volume of 2 L-BSE CSF samples (20- to 0.46 µl equivalents 
of pure CSF) were tested. These measurements revealed equivalent analytical sensitivity between CSF samples 
Figure 2. RT-QuIC sensitive detection of PrPL-BSE, PrPC-BSE and PrPscrapie from goat brain homogenates. (A) 
rHaSPrPSen 23–231 substrate was used to detect both PrPL-BSE (azure), PrPC-BSE (green) and PrPscrapie (magenta) 
from brain homogenates. 10−4 brain tissue dilutions were used to seed quadruplicate RT-QuIC reactions. 
Normal control brain homogenates (black) showed no response. The number of samples is in parentheses. 
Representative sensitivity of detection for PrPL-BSE (shades of azure; B) PrPC-BSE (shades of green; C) and 
PrPscrapie (shades of magenta; D) in brain homogenates (BH) using rHaSPrPSen 23–231 as a substrate. Dilutions 
are indicated next to the curve. (E) rHaPrPSen 90–231 substrate was used to detect both PrPL-BSE (azure) and 
PrPC-BSE (green) from brain homogenates. 10−4 brain tissue dilutions were used to seed quadruplicate RT-
QuIC reactions. Normal control brain homogenates (black) showed no response. The number of samples is in 
parentheses. (F) Representative sensitivity of detection for PrPC-BSE (shades of green) and PrPL-BSE (shades of 
azure) in brain homogenates (BH) using rHaPrPSen 90–231 as a substrate. Dilutions are indicated next to the 
curve. Similar results were obtained from two additional C-BSE-infected and two additional L-BSE-infected 
brain specimens (presented in Supplementary Fig. S3). Each ThT reading is indicated as the percentage of the 
maximum value achievable by the plate readers as a function of reaction time.
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collected at clinical onset and more than one year before clinical symptoms appeared. In each case positive reac-
tions occurred until to 0.46 µl of pure CSF seeded (Fig. 4B,C).
Furthermore, IQ-CSF conditions were used to evaluate time course of prion accumulation in the CSF of 
L-BSE-infected goats. Prion seeding activities detected in CSF samples collected 926 days post inoculum (dpi), 
1080 dpi, 1200 dpi, and at clinical onset are showed in Fig. 5A. To directly compare the amount of PrPSc in 
each time point before clinical onset, we tested endpoint serial dilutions of these CSF samples collected from 2 
L-BSE-infected goats. Finally, using Spearman-Karber analysis of the data, we estimated the dilution of pure CSF 
required to give 50% positive replicate wells under IQ-CSF conditions (the 50% seeding dose [SD50]). Initial Log 
SD50 per µl of CSF was measured at 926 dpi with an average value of 0.45. Soon thereafter, seeding activity began 
a nearly log-linear decrease down to a minimum of 0.2 LogSD50/µl CSF (Fig. 5B). This level of seeding activity 
was maintained during the remainder of the asymptomatic stage and appeared clearly increased at clinical onset.
Figure 3. Comparison of first (PQ-CSF) and second generation (IQ-CSF) of RT-QuIC assays using rHaPrPSen 
90–231. (A,B) Two L-BSE-infected (G3 and G4, blue) and uninfected (black) goat CSF were tested at 55 °C 
by using truncated rHaPrPSen 90–231 with (right) or without (left) the addition of 0.002% SDS. Two human 
CSF (red) from patients affected with sCJD were used as positive control. Distinct symbols represent separate 
samples. (C,D) Next, rHaSPrPSen 90–231 substrate was used to detect both PrPC-BSE (green) and PrPscrapie 
(magenta) from CSF of 3 symptomatic goats (G2, Sc1 and Sc2) using PQ-CSF (C) or IQ-CSF (D) of RT-QuIC 
assays.
ID
Preclinical timepoints at which 
CSF samples were collected (dpi) SV (dpi) IP (dpi)
Earlier Preclinical stage in which 
PrPSc was detected by IQ-CSF (dbo)
G5 926, 1080, 1200 1597 1500 574
G6 926, 1080 1354 1262 336
G7 926, 1200 1506 1333 407
CTR 2 926, 1080, 1200 — — —
Table 2. Preclinical timepoints at which CSF samples were collected, Survival time (SV), incubation period (IP) 
and IQ-CSF analysis in L-BSE infected goats. dpi = days post inoculum; dbo = days before onset.
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Discussion
Identification of scrapie or BSE status in goats can be complicated due to the existence of several polymorphisms 
in the PRNP coding sequence which can delay the incubation period and PrPSc accumulation34–36. A recent study 
by Madsen-Bouterse et al.37 revealed that the polymorphisms in caprine PRNP can also affect the sensitivity 
of PrPSc detection in brain samples by anti-prion mAb-based immunoassays such as IHC and Western blot 
analysis. It therefore becomes important to have a rapid, sensitive, PRNP polymorphism-independent as well 
Figure 4. Detection of pathological prion protein in CSF of L-BSE infected goats at the asymptomatic stage 
using IQ-CSF assay. (A) PrPSc detection in CSF of three L-BSE infected, but asymptomatic goats (shades of 
blue). CSF collected at 926 days post inoculum (dpi), and at clinical onset (shades of orange) from the same 
L-BSE-infected goat were tested at 55 °C by using truncated rHaPrPSen 90–231 with the addition of 0.002% SDS. 
Distinct symbols represent separate L-BSE samples. (B) analytical sensitivity of one goat L-BSE CSF collected at 
the clinical onset using IQ-CSF conditions. Reaction mixtures seeded with serial decreasing volume of L-BSE-
infected CSF samples (20- to 0.46 µl equivalents of pure CSF) were tested. Distinct symbols represent separate 
volume of pure CSF seeded. (C) analytical sensitivity of goat L-BSE-infected CSF collected 407 days before 
clinical symptoms appeared using IQ-CSF conditions. Reaction mixtures seeded with serial decreasing volume 
of L-BSE-infected CSF samples (20- to 0.46 µl equivalents of pure CSF) were tested. Distinct symbols represent 
separate volume of pure CSF seeded.
Figure 5. Time course of prion seeding activity detected in CSF of L-BSE-infected goats after intracerebral 
inoculations. (A) Prion seeding activities detected in CSF samples collected at 926 days post inoculum (dpi), 
1080 dpi, 1200 dpi, and at clinical onset from L-BSE-infected goat G5. (B) Log SD50 analysis of CSF collected 
from-L-BSE infected goats (G5, G6 and G7) at different time points of asymptomatic stage as indicated in 
Table 2. Spearman-Karber analysis of the data was used to calculate the dilution of pure CSF required to give 
50% positive replicate wells under IQ-CSF conditions (the 50% seeding dose [SD50]). Data are displayed as the 
mean + the standard deviation.
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as antibody-independent detection test to diagnose goat TSE. A previous study already demonstrated sensitive 
and specific detection of classical scrapie prions in goat brains with different genotypes by RT-QuIC38 but to 
date there is no information on experimental conditions to detect BSE prion seeding activity in small rumi-
nants. We showed that RT-QuIC can be applied successfully to a variety of brain samples from experimental 
and natural TSE-infected goats including scrapie and BSE. Our findings indicate that by using the Ha-S rPrPSen 
substrate, RT-QuIC assays can sensitively detect both C-BSE- and L-BSE-associated seeding activity in less than 
24 h. Furthermore, conversely to cattle C-BSE33, goat C-BSE prion strain was able to seed conversion of hamster 
90–231 rPrPSen substrate. These data confirm that RT-QuIC can also be used in prion strain typing, as different 
strains show slight differences in RT-QuIC response26,33,39–42.
In fact, one of the main problems related to the management of animal TSEs is the lack of rapid and sensi-
tive tests for ante-mortem diagnosis. In small ruminants TSE is suspected diagnostically on the basis of clini-
cal examination of symptomatic individuals and is confirmed post-mortem by neuropathological analysis and 
immunochemical detection of PrPSc in the central nervous system12. One important limitation to this approach 
is the sensitivity of the detection system, because amounts of PrPSc high enough to be revealed by conventional 
methods are only present in the brain at late stages of the disease. However, animal transmission studies show 
that infectivity is present at a relatively early stage of the incubation period and gradually increases as the disease 
progresses43,44. Our data indicate that RT-QuIC can amplify otherwise undetectable quantities of PrPSc from CSF 
of symptomatic and asymptomatic goats. Here, we demonstrate, for the first time, that using recombinant ham-
ster 90–231 PrPSen as substrate in combination with IQ-CSF, the diagnostic sensitivity of RT-QuIC was clearly 
improved in CSF samples of both natural scrapie and experimental BSE infected goats, allowing rapid and specific 
prion seeded polymerization in less than 40 hours. One great advantage of this improved assay is that using ham-
ster 90–231 rPrPSen substrate which can be universally applied to various animals with different PrP sequences45 
could avoid the potential problem of polymorphism in sheep or goat. Furthermore, the longitudinal study on 
experimental L-BSE goats showed that as early as two years and half after infection, i.e., at two fifths of the incu-
bation time, it is possible to distinguish infected from non-infected animals by IQ-CSF analysis. In particular, 
highly efficient detection of PrPL-BSE associated seeding activity was revealed respectively 574, 336 and 407 days 
prior to onset of clinical signs. Also, the titration of seeding activity in Fig. 4C showed very high seeding activity 
in CSF collected at 926 dpi, which suggests that this assay could be able to detect positive samples much earlier 
than 926 dpi. Moreover, Spearman-Karber analysis indicated that detectable but lower amount of PrPSc was main-
tained during the remainder of the asymptomatic stage. Similar time course in brain PrP deposition was observed 
from pre-clinical and clinical BSE cases reported by Bannach et al.46. Collectively, these data provide the first 
indications of the kinetics of prion accumulation in the CSF of prion-infected goats. The observation that PrP 
seeding activity can be detected in the CSF during early preclinical stages of the disease is consistent with a pre-
vious report showing positive RT-QuIC signal in the CSF of intracerebrally scrapie-infected hamsters before the 
clinical onset47. Clearly, the accumulation time course was highly dependent upon the route of prion inoculation. 
Indeed, the same previous study already demonstrated that after intralingual scrapie inoculation, seeding activity 
appeared in hamsters CSF only with the onset of clinical signs, well after higher-level accumulation of seeding 
activity in CSF of intracerebral challenged animals47. However, data from recent study on sheep CSF of preclinical 
and clinical naturally occurring scrapie confirmed that alterations in PrP levels and conformation are primary 
events in the pathology of prion diseases preceding neuronal damage.
Scrapie is still widespread, and the only available eradication measure is the genotype-based eradication pro-
gram. However, this plan only shows effects in years and requires a high level of compliance by farmers, which 
is not always the case. Although, furthers studies are necessary to assess the ability of RT-QuIC to detect prion 
seeding activity in biological samples of more diagnostic interest as blood and excreta, the ante-mortem CSF test 
here described is one of few ante-mortem screening methods now available to detect asymptomatic TSE-infected 
goats48. It could represent a more rapid and sensitive approach to identify TSE-infected flocks, assaying sympto-
matics and all genetically susceptible animals. Infected animals could be eliminated at an early stage, with a rapid 
decrease of the potential environmental infection load. Such a surveillance system will also allow decreases the 
genetic selection pressure, maintaining some genetic variability in the populations, as desired by farmers.
Overall, our data suggest that CSF prion seeding activity may be related to early prion pathological events 
and may allow the design of a diagnostic test for preclinical and clinical animals, minimizing the risk of potential 
exposure to others in the herd.
Materials and Methods
Study Populations and Sample Collection. The analyses with RT-QuIC were carried out on brainstem and 
CSF samples collected from goats derived from two natural outbreaks of classical scrapie and from caprines intrac-
ranially inoculated with 1 ml of a 10% (wt./vol.) brain homogenate from a cow diagnosed with classical (C-BSE) or 
atypical BSE (L-BSE) as previously described11. The physical and neurological status of the animals was monitored 
monthly by a board certified veterinary neurologist. For this purpose, a clinical examination protocol, previously 
used for sheep49 was applied. CSF was collected from the lumbosacral site of each animal, while it was standing, as 
described by Mayhew et al.50. The animal was sedated with 0.05 mg/Kg xylazine (Rompun ®, Bayer Health care) 
IV. The collection site (7 × 7 cm) was clipped, surgically prepared and locally anaesthetized with 2.0 ml of procaine 
hydrochloride (Aticain®, Ati S.r.l.). Disposable 21 G 0.80 mm × 50.00 mm hypodermal needles (Terumo ®) were 
used to collect 5 mL of CSF by gentle syringe aspiration into a sterile tube (Uridraw, Terumo ®). In the presence of 
symptomatology related to the TSE, the animals were euthanized with i.v. enbutramide/mebezonium iodide/tet-
racaine hydrochloride (Tanax®, Intervet Inc. Merck). After euthanasia, CSF, the whole brain, the entire spinal cord 
and peripheral nervous tissues were sampled. Each sample was frozen at −80 °C.
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PrPSc extraction and confirmatory Western blot (WB) analysis. PrPSc extraction and the following 
WB analyses were carried out on the brainstem samples collected at necropsy from the experimentally challenged 
goats. Brain tissue from healthy cattle, C-BSE and L-BSE samples, used for the inoculum, and goats previously 
confirmed positive or negative for classical scrapie were also analyzed as controls. The analyses were performed 
as previously reported11. PrPSc was detected using SAF84 (mouse; Cayman Chemical Co.; Cat. No. 189775) mon-
oclonal antibody and an anti-mouse antiserum conjugated with alkaline phosphatase. Reaction was revealed by 
a chemiluminescent substrate and visualized on Hyperfilm ECL (Amersham GE-Healthcare, Life Sciences) or by 
a gel documentation (UVI Prochemi, Uvitec). Image LabTM analysis software (Bio-Rad) was used to analyse blot 
images.
Recombinant prion protein purification. Syrian golden hamster residues 90 to 231 (hamster 90–231 
or Ha 90–231) and chimeric hamster-sheep (Ha-S; Syrian hamster residues 23 to 137 followed by sheep resi-
dues 141 to 234 of the R154Q171 polymorph [accession no. AY907689]) prion protein genes were ligated into the 
pET41 vector (EMD Biosciences). Escherichia coli carrying this vector was grown in Luria broth (LB) medium 
in the presence of kanamycin and chloramphenicol. rPrPSen expression was induced using Overnight Express 
Autoinduction system 1 (Novagen) and Bug Buster master mix (Novagen) to isolate inclusion bodies. Following 
solubilisation of the inclusion bodies in 8M guanidinium-HCl, the denatured protein was purified under 6M 
guanidinium-HCl denaturing conditions using nickel nitrilotriacetic acid (Ni-NTA) superflow resin (Qiagen) 
with an AKTA 25 L protein liquid chromatography instrument (GE-Healthcare, Life Sciences). The rPrPSen was 
subjected to on-column refolding using a linear gradient into phosphate buffer and then eluted using an imida-
zole gradient as previously described14. The purified protein was extensively dialyzed into 10 mM sodium phos-
phate buffer (pH 5.8). Then, following filtration (0.22-µm syringe filter; Sartorius), a concentration measurement 
by absorbance at 280 nm was performed and the rPrPSen was stored at −80 °C.
Brain homogenates preparation and RT-QuIC protocol. Normal (n = 2), scrapie-infected (n = 2), 
C-BSE-infected (n = 2), and L-BSE-infected (n = 2) goat brain homogenates (BHs) (10%, wt/vol) were prepared 
as previously described33 and stored at −80 °C. For RT-QuIC analysis, BHs were serially diluted in 0.1% SDS 
(Sigma)–N2 (Gibco)–PBS as previously reported14. The RT-QuIC reaction mix was composed of 10 mM phos-
phate buffer (pH 7.4), 300 mM NaCl, 10 µM ThT, 1 mM EDTA, and 0.1 mg/ml of rPrPSen. Aliquots of this mix 
(98 µl) were loaded into each well of a black 96-well plate with a clear bottom (Nunc) and seeded with 2 µl of 
10−4 to 10−9 brain homogenate dilutions. Normal goat BH dilutions were used as negative controls (as shown in 
Fig. 2), and 10−4 brain homogenate dilutions from bovine or sheep with clinical BSE or scrapie, respectively, were 
initially included as positive controls when goat brain samples were tested for the first time. The plate was then 
sealed with a plate-sealer film (Nalgene Nunc International) and incubated for 70 h at 42 °C in a BMG Labtech 
FLUOstar plate reader with cycles of 1 min of shaking (700 rpm double orbital) and 1 min of rest throughout 
the incubation. ThT fluorescence measurements (excitation, 450 ± 10 nm; emission, 480 ± 10 nm; bottom read) 
were recorded every 45 min. RT-QuIC reactions were deemed acceptable when the negative controls remained 
negative for at least 50 h.
CSF preparation, PQ-CSF and IQ-CSF protocols. Native CSF samples were centrifuged at 1000 × g 
for 10 min to remove cell debris, using 5417 R Eppendorf centrifuge (or an equivalent). Supernatant was trans-
ferred to new 1.5-ml tubes and stored at −20 °C. IQ-CSF assays were performed as reported previously for sCJD 
patients25. Briefly, both PQ-CSF and IQ-CSF reactions were run with rPrPSen Ha 90–231 with or without the 
addition of 0.002% SDS to the reaction mix.
Data analysis. RT-QuIC fluorescence readings were analyzed as previously described33. Briefly, to compen-
sate for differences between the fluorescence plate readers, data sets were normalized to a percentage of the max-
imal fluorescence response of the instrument, and the obtained values were plotted against the reaction times. 
Samples were judged to be RT-QuIC positive using criteria similar to those previously described for RT-QuIC 
analyses of brain specimens14,33. A 60 h time point was chosen based on multiple (n = 20) repeat runs in which 
no spontaneous conversions of the substrate in negative-control seeded reactions were observed up to the exper-
imentally designated time point. Data are displayed as the average of four technical replicates except where 
indicated. Where multiple biological replicates are displayed, they are represented as the mean ± the standard 
deviation.
Ethics Statement. All procedures involving animals and their care were conducted in conformity with 
national and international laws and policies (EEC Council Directive 86/609, 63/2010; Italian Legislative Decree 
116/92 and 26/2014). The study was approved by the Italian Ministry of Health with authorization number 
694/2015-PR of 17th of July 2015.
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